Franklin Biotechnology Discovery Fund

Portfolio Statistics

Assets

Total Fund AssetsAs of 10/31/2019 (updated monthly) $1,084.2 (M)
Net Assets - Class C As of 10/31/2019 (updated monthly) $43.9 (M)
P/E Ratio (12-mo Forward)As of 10/31/2019 (updated monthly) 15.69
P/B RatioAs of 10/31/2019 (updated monthly) 5.46

Positions As of 10/31/2019

Portfolio Details

Asset AllocationAs of 10/31/2019

[name] [value]
Equity 98.02%
Cash & Cash Equivalents 1.98%

Geographic BreakdownAs of 10/31/2019

[name] [value]
United States 85.31%
United Kingdom 4.25%
Netherlands 3.05%
Denmark 2.63%
Cash & Cash Equivalents 1.98%
Canada 1.07%
Switzerland 0.77%
Germany 0.69%
Ireland 0.25%

sector breakdownAs of 10/31/2019

[name] [value]
Biotechnology 79.30%
Pharmaceuticals 13.92%
Life Sciences Tools & Services 4.80%
Cash & Cash Equivalents 1.98%

TOP TEN HOLDINGSAs of 10/31/2019

51.14%
Other
0% 100%
[holdings-table-heading]
AMGEN INC 8.10%
VERTEX PHARMACEUTICALS INC 6.80%
GILEAD SCIENCES INC 6.12%
BIOGEN INC 5.22%
ILLUMINA INC 4.80%
REATA PHARMACEUTICALS INC 4.61%
GW PHARMACEUTICALS PLC 4.25%
REGENERON PHARMACEUTICALS INC 4.05%
IOVANCE BIOTHERAPEUTICS INC 3.88%
ALEXION PHARMACEUTICALS INC 3.31%

No content selected